{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:21:31Z","timestamp":1789410091107,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ejim.2013.01.002","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T03:45:19Z","timestamp":1359690319000},"page":"474-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome"],"prefix":"10.1016","volume":"24","author":[{"given":"I.","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Josse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Decaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Diot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Landron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Roblot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jouneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.Y.","family":"Hatron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Vittecoq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Jouen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dominique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.01.002_bb0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes","volume":"77","author":"Marguerie","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.ejim.2013.01.002_bb0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.rmed.2012.01.001","article-title":"Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome","volume":"106","author":"Marie","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2013.01.002_bb0015","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","article-title":"Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody","volume":"41","author":"Marie","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.01.002_bb0020","article-title":"Interstitial lung disease in anti-jo1 patients with antisynthetase syndrome","author":"Marie","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ejim.2013.01.002_bb0025","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies. What progress has been made in the past 35years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2013.01.002_bb0030","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","article-title":"Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes","volume":"9","author":"Koenig","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ejim.2013.01.002_bb0035","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/BOR.0b013e328358bd85","article-title":"Myositis autoantibodies","volume":"24","author":"Casciola-Rosen","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ejim.2013.01.002_bb0040","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","article-title":"Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome","volume":"11","author":"Marie","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2013.01.002_bb0045","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis: first of two parts","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.01.002_bb0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis: second of two parts","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.01.002_bb0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002281-199911000-00005","article-title":"Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis","volume":"11","author":"Sontheimer","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ejim.2013.01.002_bb0060","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/acr.20325","article-title":"Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients","volume":"62","author":"Marie","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ejim.2013.01.002_bb0065","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.01.002_bb0070","first-page":"1","article-title":"Clinical respiratory physiology: standardized lung function testing: working party report: standardization of lung function tests","volume":"19","author":"Quanjer","year":"1983","journal-title":"Bull Eur Physiopathol Respir"},{"key":"10.1016\/j.ejim.2013.01.002_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/thorax.58.2.143","article-title":"Radiological versus histological diagnosis in UIP and NSIP: survival implications","volume":"58","author":"Flaherty","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.ejim.2013.01.002_bb0080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005382-199623000-00002","article-title":"High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis","volume":"11","author":"Ikezoe","year":"1996","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.ejim.2013.01.002_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2214\/ajr.169.1.9207505","article-title":"Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT","volume":"169","author":"Mino","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejim.2013.01.002_bb0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2483071378","article-title":"Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study","volume":"249","author":"Shin","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.ejim.2013.01.002_bb0095","first-page":"1520","article-title":"High resolution computed tomography in early scleroderma lung disease","volume":"18","author":"Warrick","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.01.002_bb0100","first-page":"2230","article-title":"Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.01.002_bb0105","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.01.002_bb0110","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1445-5994.2010.02164.x","article-title":"Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies","volume":"41","author":"Dugar","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.ejim.2013.01.002_bb0115","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.rmed.2009.05.001","article-title":"Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia","volume":"103","author":"Fischer","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2013.01.002_bb0120","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1183\/09031936.00104310","article-title":"Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies","volume":"37","author":"Hervier","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2013.01.002_bb0125","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e318260977c","article-title":"Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature","volume":"91","author":"Labirua-Iturburu","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2013.01.002_bb0130","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1084\/jem.160.2.420","article-title":"Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody","volume":"160","author":"Mathews","year":"1984","journal-title":"J Exp Med"},{"key":"10.1016\/j.ejim.2013.01.002_bb0135","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.1780310408","article-title":"Antibody to threonyl-transfer RNA synthetase in myositis sera","volume":"31","author":"Targoff","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.01.002_bb0140","first-page":"609","article-title":"Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies","volume":"23","author":"Sato","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2013.01.002_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jbspin.2009.08.008","article-title":"Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective study of 169 patients","volume":"77","author":"Vancsa","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ejim.2013.01.002_bb0150","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.21883","article-title":"Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis\/dermatomyositis","volume":"54","author":"Yamasaki","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.01.002_bb0155","first-page":"1336","article-title":"Pulmonary involvement in polymyositis and in dermatomyositis","volume":"25","author":"Marie","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.01.002_bb0160","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MCP.0b013e32833cc997","article-title":"The role of high-resolution computed tomography in the work-up of interstitial lung disease","volume":"16","author":"Verschakelen","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ejim.2013.01.002_bb0165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.autrev.2011.06.007","article-title":"Therapy of polymyositis and dermatomyositis","volume":"11","author":"Marie","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2013.01.002_bb0170","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/rheumatology\/40.9.1072","article-title":"Intravenous immunoglobulins and octreotide as treatment of intestinal pseudo-obstruction revealing a recurrence of polymyositis","volume":"40","author":"Marie","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2013.01.002_bb0175","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00000441-200612000-00003","article-title":"Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association","volume":"332","author":"Tweezer-Zaks","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ejim.2013.01.002_bb0180","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T02:02:40Z","timestamp":1539914560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0953620513000071"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.01.002","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}